GSK2982772 is an experimental selective inhibitor of receptor-interacting protein kinase 1 (RIPK1), being investigated for the treatment of inflammatory diseases. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include GTPL9554 and orb1300025. Its PubChem CID is 77108121.
Gsk2982772
| CAS No | 1622848-92-3 |
|---|---|
| Molecular Formula | C20H19N5O3 |
| Molecular Weight | 377.4 g/mol |
| Synonyms | 5-benzyl-N-[(3S)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-1H-1,2,4-triazole-3-carboxamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
GSK2982772 is an experimental selective inhibitor of receptor-interacting protein kinase 1 (RIPK1), being investigated for the treatment of inflammatory diseases.
The listed CAS number is 1622848-92-3.
The listed molecular formula is C20H19N5O3.
The listed molecular weight is 377.4 g/mol.
5-benzyl-N-[(3S)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-1H-1,2,4-triazole-3-carboxamide.
The source lists GTPL9554 and orb1300025.